Analysis of the curative effect of endoscopic band ligation combined with drug injection in the treatment ;of hepatic cirrhosis complicated with upper gastrointestinal haemorrhage
10.3969/j.issn.1006-5725.2016.12.038
- VernacularTitle:内镜下套扎联合药物注射治疗肝硬化合并上消化道出血的疗效
- Author:
Wenjing LIANG
;
Yingtian FU
;
Yanfeng LI
;
Yanjing CHEN
- Publication Type:Journal Article
- Keywords:
Endoscopic band ligation;
Hepatic cirrhosis;
Upper gastrointestinal hemorrhage;
Hemodynamics
- From:
The Journal of Practical Medicine
2016;32(12):2017-2019
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the curative effects of endoscopic band ligation combined with drug injection in the treatment of hepatic cirrhosis complicated with upper gastrointestinal hemorrhage. Methods 76 patients with hepatic cirrhosis complicated with upper gastrointestinal hemorrhage were divided into 2 groups by random double blind method, with 38 cases in each group. The control group were treated by conservative regimen alone while the experimental group were treated by endoscopic band ligation combined with drug injection, based on the control group. The clinical curative effects, adverse reactions, hemostasis time, hospitalization time , rebleeding , haemodynamics and other indexes before and after the treatment in the 2 groups were compared. Results The total effective rate, rebleeding rate and the incidence of fever in the experimental group were 2.6% and 10.5%, respectively. Compared with those in the control group (71.1%, 21.1%, 28.9%), the differences were statistically significant (P < 0.05). The differences in volume of blood transfusion, hemostasis time , time of improvement of symptoms and hospitalization time between the experimental group and the control group were significant (P < 0.01). The blood flow of portal vein(550.2 ± 143.4)mL and splenic vein (284.3 ± 96.4)mLin the experimental group was significantly less than that in the control group [(628.1 ± 156.0)mL, (332.6 ± 100.3)mL] (P < 0.05). Condusions Endoscopic band ligation combined with drug injection in the treatment of hepatic cirrhosis complicated with upper gastrointestinal hemorrhage is effective and can significantly improve the varicose hemodynamics in patients. The rate of rebleeding is low.
